2024 Q3 Form 10-K Financial Statement

#000149315224026882 Filed on July 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2024
Revenue $0.00 $4.000K
YoY Change -100.0% -84.0%
Cost Of Revenue $72.90K $1.600K
YoY Change 80.49% -96.04%
Gross Profit -$72.90K -$70.50K
YoY Change 373.68% 358.09%
Gross Profit Margin -1762.5%
Selling, General & Admin $307.8K $1.400M
YoY Change -23.63% 33.06%
% of Gross Profit
Research & Development $24.86K $104.5K
YoY Change 4563.39%
% of Gross Profit
Depreciation & Amortization $32.80K $111.9K
YoY Change 406.17% 244.75%
% of Gross Profit
Operating Expenses $229.8K $332.6K $1.554M
YoY Change -45.97% -17.46% 47.67%
Operating Profit -$229.8K -$405.5K -$1.624M
YoY Change -45.74% -3.08% 52.14%
Interest Expense $10.00 $11.09K
YoY Change -100.7% -324.95%
% of Operating Profit
Other Income/Expense, Net -$4.245K $11.09K
YoY Change -150.9% -325.02%
Pretax Income -$234.1K -$408.8K -$1.613M
YoY Change -43.63% -6.94% 44.18%
Income Tax
% Of Pretax Income
Net Earnings -$234.1K -$408.8K -$1.613M
YoY Change -43.63% -6.94% 44.18%
Net Earnings / Revenue -40328.5%
Basic Earnings Per Share -$0.02 -$0.14
Diluted Earnings Per Share -$0.02 -$0.03 -$0.14
COMMON SHARES
Basic Shares Outstanding 12.09M shares 12.07M shares 11.88M shares
Diluted Shares Outstanding 12.12M shares 11.88M shares

Balance Sheet

Concept 2024 Q3 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.06K $75.06K
YoY Change -88.77% -88.77%
Cash & Equivalents $11.98K $75.06K
Short-Term Investments
Other Short-Term Assets $6.760K $6.760K
YoY Change -4.11% -4.11%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $18.73K $81.82K $81.82K
YoY Change -97.23% -89.09% -89.09%
LONG-TERM ASSETS
Property, Plant & Equipment $203.0K $268.6K $348.1K
YoY Change -35.37% 180.69% 263.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.390K $4.390K
YoY Change
Total Long-Term Assets $817.1K $904.2K $904.2K
YoY Change -13.75% 274.29% 274.29%
TOTAL ASSETS
Total Short-Term Assets $18.73K $81.82K $81.82K
Total Long-Term Assets $817.1K $904.2K $904.2K
Total Assets $835.8K $986.0K $986.0K
YoY Change -48.53% -0.53% -0.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $685.3K $685.3K
YoY Change 43.46% 43.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $906.6K $705.9K $705.9K
YoY Change 36.92% 40.21% 40.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $35.37K $35.37K
YoY Change 42.28% 42.28%
Total Long-Term Liabilities $35.37K $35.37K
YoY Change 42.28% 42.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $906.6K $705.9K $705.9K
Total Long-Term Liabilities $35.37K $35.37K
Total Liabilities $924.4K $741.2K $741.2K
YoY Change 28.58% 40.3% 40.3%
SHAREHOLDERS EQUITY
Retained Earnings -$4.365M -$3.872M
YoY Change 45.66% 71.42%
Common Stock $12.13K $12.07K
YoY Change 0.77% 16.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$88.62K $244.8K $244.8K
YoY Change
Total Liabilities & Shareholders Equity $835.8K $986.0K $986.0K
YoY Change -48.53% -0.53% -0.53%

Cashflow Statement

Concept 2024 Q3 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$234.1K -$408.8K -$1.613M
YoY Change -43.63% -6.94% 44.18%
Depreciation, Depletion And Amortization $32.80K $111.9K
YoY Change 406.17% 244.75%
Cash From Operating Activities -$198.6K -$1.147M
YoY Change 316.66% 245.84%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $333.2K
YoY Change -100.0% 1061.15%
Acquisitions
YoY Change
Other Investing Activities -$50.00K -$102.3K
YoY Change
Cash From Investing Activities -$50.00K -$841.3K
YoY Change 74.22% 2831.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.335M
YoY Change 258.39%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 185.0K $1.395M
YoY Change -70.05% 41.33%
NET CHANGE
Cash From Operating Activities -198.6K -$1.147M
Cash From Investing Activities -50.00K -$841.3K
Cash From Financing Activities 185.0K $1.395M
Net Change In Cash -63.58K -$593.1K
YoY Change -111.74% -194.62%
FREE CASH FLOW
Cash From Operating Activities -$198.6K -$1.147M
Capital Expenditures $0.00 $333.2K
Free Cash Flow -$198.6K -$1.480M
YoY Change 160.06% 310.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001496690
CY2024Q1 us-gaap Inventory Net
InventoryNet
usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2024 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
usd
CY2024 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2024 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
usd
CY2024 us-gaap Repayments Of Debt
RepaymentsOfDebt
usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024 BCRD Sale Of Vehicle
SaleOfVehicle
usd
CY2024 BCRD Reclassification Of Prepaid Assets To Software Development
ReclassificationOfPrepaidAssetsToSoftwareDevelopment
usd
CY2023 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
usd
CY2024Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
usd
CY2023Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.001
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
15320205 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12087454 shares
CY2024 dei Auditor Firm
AuditorFirmId
106
CY2024 dei Auditor Name
AuditorName
Salberg & Company, P.A.
CY2024 dei Auditor Location
AuditorLocation
Boca Raton, Florida
CY2024Q1 us-gaap Cash
Cash
75063 usd
CY2023Q1 us-gaap Cash
Cash
668118 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
74500 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6759 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7048 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
81822 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
749666 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
268593 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47287 usd
CY2024Q1 BCRD Internal Use Software Development
InternalUseSoftwareDevelopment
551683 usd
CY2023Q1 BCRD Internal Use Software Development
InternalUseSoftwareDevelopment
145892 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
79543 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
48401 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
4391 usd
CY2024Q1 us-gaap Assets
Assets
986032 usd
CY2023Q1 us-gaap Assets
Assets
991246 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
72473 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
79543 usd
CY2024Q1 BCRD Compensation Payable
CompensationPayable
571325 usd
CY2023Q1 BCRD Compensation Payable
CompensationPayable
380750 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20595 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25765 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41466 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17384 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
705859 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
503442 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35371 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24862 usd
CY2024Q1 us-gaap Liabilities
Liabilities
741230 usd
CY2023Q1 us-gaap Liabilities
Liabilities
528304 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
292 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
292 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12072454 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12072454 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10336004 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10336004 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
12073 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
10336 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4044189 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2093226 usd
CY2024Q1 BCRD Stock Subscription Received
StockSubscriptionReceived
60000 usd
CY2023Q1 BCRD Stock Subscription Received
StockSubscriptionReceived
617700 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3871752 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2258612 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
244802 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
462942 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
986032 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
991246 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25000 usd
CY2024 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1600 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14000 usd
CY2024 BCRD Cost Of Sales Inventory Reserve
CostOfSalesInventoryReserve
72900 usd
CY2023 BCRD Cost Of Sales Inventory Reserve
CostOfSalesInventoryReserve
26385 usd
CY2024 us-gaap Gross Profit
GrossProfit
-70500 usd
CY2023 us-gaap Gross Profit
GrossProfit
-15385 usd
CY2024 us-gaap Legal Fees
LegalFees
49251 usd
CY2023 us-gaap Legal Fees
LegalFees
44102 usd
CY2024 BCRD Rent Expense
RentExpense
151163 usd
CY2023 BCRD Rent Expense
RentExpense
99598 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
954786 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-1624229 usd
CY2024 us-gaap Interest Income Other
InterestIncomeOther
11137 usd
CY2024 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
48 usd
CY2023 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4928 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11089 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4928 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1613140 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1118799 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-1613140 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1118799 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11879652 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11879652 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10293125 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10293125 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
462942 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1335000 usd
CY2024 BCRD Stock Subscriptions Received
StockSubscriptionsReceived
60000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-1613140 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
244802 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
91541 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
91541 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
372500 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
500000 usd
CY2023 BCRD Stock Subscriptions Received
StockSubscriptionsReceived
617700 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
462942 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
462942 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-1613140 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111943 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32470 usd
CY2024 us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
72900 usd
CY2023 us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
26385 usd
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
102305 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
6155 usd
CY2023 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-2196 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
500000 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1600 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22985 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-289 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-68366 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8012 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
40445 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-20000 usd
CY2024 BCRD Increase Decrease In Compensation Payable
IncreaseDecreaseInCompensationPayable
190575 usd
CY2023 BCRD Increase Decrease In Compensation Payable
IncreaseDecreaseInCompensationPayable
173250 usd
CY2024 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-5170 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-6747 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1146710 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-331574 usd
CY2024 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
405791 usd
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
28700 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
333249 usd
CY2024 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
102305 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-841345 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28700 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1335000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
372500 usd
CY2024 BCRD Proceed From Cash Received From Stock Subscriptions
ProceedFromCashReceivedFromStockSubscriptions
60000 usd
CY2023 BCRD Proceed From Cash Received From Stock Subscriptions
ProceedFromCashReceivedFromStockSubscriptions
617700 usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
3126 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1395000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
987074 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-593055 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
626800 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
668118 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41318 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
75063 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
668118 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
41 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
3510 usd
CY2023 BCRD Sale Of Vehicle
SaleOfVehicle
53494 usd
CY2024 BCRD Present Value Of Initial Lease Liability And Rightofuse Asset
PresentValueOfInitialLeaseLiabilityAndRightofuseAsset
70844 usd
CY2023 BCRD Present Value Of Initial Lease Liability And Rightofuse Asset
PresentValueOfInitialLeaseLiabilityAndRightofuseAsset
62113 usd
CY2023 BCRD Reclassification Of Prepaid Assets To Software Development
ReclassificationOfPrepaidAssetsToSoftwareDevelopment
117192 usd
CY2024 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_800_eus-gaap--NatureOfOperations_zaiNd5fVg1yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_825_z1wGkcvT28ul">NATURE OF OPERATIONS AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BlueOne Card, Inc. (“BlueOne” or the “Company”), was incorporated on July 6, 2007 under the laws of the state of Nevada. The Company intends to provide innovative payout solutions and prepaid debit card and gift card solutions to consumers and corporations transforming card-to-card cross border real time global money transfers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements have been prepared on a going concern basis which contemplates the realization of assets and settlement of liabilities and commitments in the normal course of business. The Company has not yet generated any significant revenues and has suffered operating losses since July 6, 2007 (Inception Date) to date. The Company recorded a net loss of $<span id="xdx_90A_eus-gaap--NetIncomeLoss_di_c20230401__20240331_zgMA8cq9Va48" title="Net income loss">1,613,140</span>, and used net cash flows in operating activities of $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_di_c20230401__20240331_zfjZjYgjtCgj" title="Net cash provided by (used in) operating activities">1,146,710</span> during fiscal 2024, has a working capital deficit of $<span id="xdx_901_ecustom--WorkingCapitalDeficit_iI_c20240331_zlVDlLXzBhs8" title="Working capital deficit">624,037</span>, and an accumulated deficit of $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_di_c20240331_zFpOaq15p7T9" title="Accumulated deficit">3,871,752</span> as of March 31, 2024. These factors, among others, raise a substantial doubt regarding the Company’s ability to continue as a going concern operations for a period of 12 months from the issuance date of these financial statements. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary financing to continue operations, and the attainment of profitability. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-1613140 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1146710 usd
CY2024Q1 BCRD Working Capital Deficit
WorkingCapitalDeficit
624037 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3871752 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zPnvUiGF1Vkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of its assets, liabilities, equity and operations. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about its estimates that are not readily apparent from other sources. Significant estimates in the accompanying financial statements include the valuation of inventory, internal-use software development costs, right-of-use assets, stock-based compensation and deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z17kANiOof4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash Concentration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash is maintained at one financial institution and at times, balances may exceed federally insured limits. We have not experienced any losses related to these balances. As of March 31, 2024, the Company did not have any cash balances in a financial institution which exceeded federally insured limits. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operation and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customer Concentration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended March 31, 2024, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zCaU2VXIRWee" title="Customer concentration, percentage">100%</span> of revenue was derived from sales to two customers. For the year ended March 31, 2023, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zM4R7UQBxoVk" title="Customer concentration, percentage">100%</span> of the revenues were derived from two sales to one customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Vendor and Concentration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company relied solely on one vendor for key components and processing services related to the manufacturing, distribution and servicing of its prepaid debit cards and gift cards. The same vendor was also the sole developer and provider of the software for Company’s operations. The Company terminated its relationship with this vendor on or around December 18, 2023, and entered into an agreement with a new vendor on February 27, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
72900 usd
CY2023Q1 us-gaap Inventory Adjustments
InventoryAdjustments
26385 usd
CY2024 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
102305 usd
CY2024Q1 BCRD Allowance For Uncollectable Loans Receivables Percentage
AllowanceForUncollectableLoansReceivablesPercentage
1 pure
CY2023Q1 BCRD Allowance For Uncollectable Loans Receivables Percentage
AllowanceForUncollectableLoansReceivablesPercentage
1 pure
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
CY2024 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25000 usd
CY2024 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
488838 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
74713 usd
CY2024 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
more than 50 percent
CY2024 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1613140 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1118799 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11879652 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11879652 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10293125 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10293125 shares
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
292000000 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
292000000 shares
CY2024Q1 us-gaap Other Inventory
OtherInventory
99285 usd
CY2023Q1 us-gaap Other Inventory
OtherInventory
100885 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
99285 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
26385 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
74500 usd
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
72900 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
459268 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
126019 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
190675 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78732 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
268593 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47287 usd
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111943 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32470 usd
CY2024 BCRD Capitalized Costs
CapitalizedCosts
405791 usd
CY2023 BCRD Capitalized Costs
CapitalizedCosts
145892 usd
CY2024Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
551683 usd
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
145892 usd
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
551683 usd
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
145892 usd
CY2024 us-gaap Officers Compensation
OfficersCompensation
190575 usd
CY2023 us-gaap Officers Compensation
OfficersCompensation
173250 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
79543 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41466 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35371 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
76837 usd
CY2023Q2 BCRD Right Of Use Asset And Lease Liability
RightOfUseAssetAndLeaseLiability
70844 usd
CY2024 us-gaap Payments For Rent
PaymentsForRent
151163 usd
CY2023 us-gaap Payments For Rent
PaymentsForRent
99598 usd
CY2024Q1 BCRD Due Diligence Fee
DueDiligenceFee
5000 usd
CY2024Q1 BCRD Purchase Obligation Due In Three Months
PurchaseObligationDueInThreeMonths
0 usd
CY2024Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
5000 usd
CY2024Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
10000 usd
CY2024Q1 BCRD Purchase Obligation Due After Third Year
PurchaseObligationDueAfterThirdYear
15000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 BCRD Common Stock Subscription Received
CommonStockSubscriptionReceived
1952700 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12072454 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12072454 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10336004 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10336004 shares
CY2024Q1 us-gaap Debt Instrument Convertible Liquidation Preference Per Share
DebtInstrumentConvertibleLiquidationPreferencePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
292000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
292000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
292000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
292000 shares
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0698 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0698 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2798 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2798 pure
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
664164 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
229953 usd
CY2024Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
664164 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
229953 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
664164 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
229953 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3341000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1741000 usd
CY2023 BCRD Cumulative Deferred Tax Assets Valuation Allowance Percentage
CumulativeDeferredTaxAssetsValuationAllowancePercentage
1 pure
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
434211 usd

Files In Submission

Name View Source Status
0001493152-24-026882-index-headers.html Edgar Link pending
0001493152-24-026882-index.html Edgar Link pending
0001493152-24-026882.txt Edgar Link pending
0001493152-24-026882-xbrl.zip Edgar Link pending
bcrd-20240331.xsd Edgar Link pending
ex10-6.htm Edgar Link pending
ex10-6_001.jpg Edgar Link pending
ex10-6_002.jpg Edgar Link pending
ex10-6_003.jpg Edgar Link pending
ex10-6_004.jpg Edgar Link pending
ex10-6_005.jpg Edgar Link pending
ex10-6_006.jpg Edgar Link pending
ex10-6_007.jpg Edgar Link pending
ex10-6_008.jpg Edgar Link pending
ex10-6_009.jpg Edgar Link pending
ex10-6_010.jpg Edgar Link pending
ex10-6_011.jpg Edgar Link pending
ex10-6_012.jpg Edgar Link pending
ex10-6_013.jpg Edgar Link pending
ex10-6_014.jpg Edgar Link pending
ex10-6_015.jpg Edgar Link pending
ex10-6_016.jpg Edgar Link pending
ex10-6_017.jpg Edgar Link pending
ex10-6_018.jpg Edgar Link pending
ex10-6_019.jpg Edgar Link pending
bcrd-20240331_cal.xml Edgar Link unprocessable
bcrd-20240331_def.xml Edgar Link unprocessable
bcrd-20240331_lab.xml Edgar Link unprocessable
bcrd-20240331_pre.xml Edgar Link unprocessable
ex10-6_020.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable